• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • China Regulatory Measures for Self-testing Finalized

China Regulatory Measures for Self-testing Finalized

Tuesday, 23 November 2021 / Published in Medical Device, News, NMPA Registration in China

China Regulatory Measures for Self-testing Finalized

On October 22, 2021, the NMPA (National Medical Products Administration) published (No.126-2021) the Regulations on Self-test of Medical Device Registration.

The first draft of the self-test regulation was released days after the launch of the Order 739 where it was officially introduced, and later on, the NMPA solicited for public comments on the revised draft in July 2021.

Following our detailed review of the regulations, our current view is that it is nearly impossible for importing manufacturers to fulfil the requirements for self-test because the foreign manufacturer has to do the tests strictly according to Chinese standards. So for our customers we continue to recommend from a risk, timing and cost perspective to undertake sample testing with NMPA certified test labs in China.

Highlights

  • The NMPA can accept self-testing reports that are issued by self-owned laboratories of applicants in support of medical device registration in China.
  • The NMPA can accept a combination of self-testing reports issued by a self-owned laboratory of the applicant, and other laboratories appointed by the applicant. However, the laboratory appointed by the applicant needs to have a CMA qualification certificate.
  • The NMPA can accept self-testing reports that are all from other laboratories appointed by the applicant. However, the laboratory appointed by the applicant needs to have a CMA (China Inspection Body and Laboratory Mandatory Approval) qualification certificate.
  • When submitting the self-testing report, the self-testing capability declaration statement and QMS (quality management system) related supporting documents can be exempted if:
    • The self-testing report submitted by domestic applicants is issued by a self-owned laboratory with CNAS (China National Accreditation Service for Conformity Assessment) accreditation; or
    • The self-testing report submitted by foreign applicants is issued by a self-owned laboratory with approval from the applicant’s government.

As a supporting regulation to Order 739, the finalized regulation requires the medical device registration applicants or filing persons to incorporate self-testing into the medical device quality management system, and possess self-testing capabilities in terms of staff, equipment, sample management, quality and record control. Inspectors, test laboratories, manufacturing subcontractors and corporate groups are also obliged to meet the self-testing requirements.

By Alice Liu and Jacky Li. Contact Cisema if you would like to learn more.

What you can read next

Biocompatibility Testing in China of Medical Devices: Regulatory Update
china clinical trials drugs GMP
China Clinical Trials for Drugs GMP appendix has been released
China drug standards draft measures
China drug standards draft measures have been published by the NMPA

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China medical device sampling inspection results

    China medical device sampling inspection results no.4 of 2022

    China medical device sampling inspection result...
  • NMPA cosmetic sampling inspection

    The NMPA Cosmetic Sampling Inspection measures come into force on March 1, 2023

    NMPA Cosmetic Sampling Inspection Measures come...
  • China cosmetics quality safety responsibilities

    China cosmetics quality and safety responsibilities regulations released

    China cosmetics quality and safety responsibili...
  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.